Inventor
VAN DER PLAS STEVEN EMIEL
BE23 patents
⚠️ This page may combine multiple inventors who share the name “VAN DER PLAS STEVEN EMIEL”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
GALAPAGOS NV
9 patentsUS9133210B2Sep 15, 2015
Compounds and pharmaceutical compositions thereof for the treatment of cystic fibrosis
GALAPAGOS NV4 citations81
US10568867B2Feb 25, 2020
Compounds and pharmaceutical compositions thereof for the treatment of cystic fibrosis
GALAPAGOS NV1 citations70
US9351955B2May 31, 2016
Compounds and pharmaceutical compositions thereof for the treatment of cystic fibrosis
GALAPAGOS NV3 citations70
US11564923B2Jan 31, 2023
Compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders
GALAPAGOS NV2 citations68
US9895347B2Feb 20, 2018
Compounds and pharmaceutical compositions thereof for the treatment of cystic fibrosis
GALAPAGOS NV3 citations67
US9382254B2Jul 5, 2016
Compounds and pharmaceutical compositions thereof for the treatment of cystic fibrosis
GALAPAGOS NV2 citations57
US12472181B2Nov 18, 2025
Compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders
GALAPAGOS NV0 citations56
US9867806B2Jan 16, 2018
Compounds and pharmaceutical compositions thereof for the treatment of cystic fibrosis
GALAPAGOS NV0 citations47
US10508111B2Dec 17, 2019
6-[5-amino-6-(2-ethoxyethoxy)-imidazo[4,5-B]pyridin-3-yl]-nicotinonitrile derivatives and their use as IRAK inhibitors
GALAPAGOS NV0 citations34
ABBVIE SARL
7 patentsUS10138227B2Nov 27, 2018
Heteroaryl substituted pyridines and methods of use
ABBVIE SARL31 citations92
US10259810B2Apr 16, 2019
N-sulfonylated pyrazolo[3,4-b]pyridin-6-carboxamides and method of use
ABBVIE SARL5 citations82
US9890158B2Feb 13, 2018
N-sulfonylated pyrazolo[3,4-b]pyridin-6-carboxamides and method of use
ABBVIE SARL5 citations81
US10647717B2May 12, 2020
N-sulfonylated-pyrazolo[3,4-b]pyridin-6-carboxamides and method of use
ABBVIE SARL1 citations71
US10604515B2Mar 31, 2020
Heteroaryl substituted pyridines and methods of use
ABBVIE SARL1 citations61
US10428017B2Oct 1, 2019
Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use
ABBVIE SARL1 citations61
US10130622B2Nov 20, 2018
Compounds for treatment of cystic fibrosis
ABBVIE SARL0 citations37
ABBVIE OVERSEAS SARL
5 patentsUS10988454B2Apr 27, 2021
Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use
ABBVIE OVERSEAS SARL1 citations70
US10981890B2Apr 20, 2021
Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use
ABBVIE OVERSEAS SARL0 citations59
US10844042B2Nov 24, 2020
Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use
ABBVIE OVERSEAS SARL0 citations49
US10844041B2Nov 24, 2020
Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use
ABBVIE OVERSEAS SARL0 citations49
US10829473B2Nov 10, 2020
Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use
ABBVIE OVERSEAS SARL0 citations49